CBS VIDEO + ARTICLE: Excitement and Hope are 2 words not often heard in Alzheimer’s clinical trials, but new results for solanezumab are generating quite
Diabetics get a lot more dementia than the average person. Yet diabetics taking FDA-approved Actos get a lot LESS dementia than the average person – 47% less. That’s about half the rate. Find out more.
VIDEO + ARTICLE: Diagnostic technology is a powerful weapon in the fight against dementia. Find out how a new map of the ageing brain will
A startling new link shows Alzheimer’s in transplant patients is significantly lower, in fact almost absent, when compared to national data from the general population.
Lymphatic systems serve many tasks, including the draining of waste proteins. A unexpected new discovery found it reaches brain cells. Can it be boosted to
VIDEO + ARTICLE: A new epilepsy drug could be used to treat Alzheimer’s patients. Find out about this new experimental approach.
MEDICATION TRIALS: Although Astra Zeneca’s AZD05030 disappointed cancer researchers, it surprisingly blocked the damage caused by Alzheimer’s plaque. Learn about the speed with which this
VIDEO + ARTICLE: For 25 years, researchers tried curing Alzheimer’s by clearing amyloid plaque. While plaque is a problem, is it merely Alzheimer’s cargo, while
VIDEO: “For the first time I think we have a chance to really change the course of Alzheimer’s disease,” says Dr. Reisa Sperling. She’s leading
VIDEO & ARTICLE: CNBC’s Meg Tirrell reports on Biogen’s experimental drug for Alzheimer’s and how the company appears to have exceeded expectations.
What caregivers should know about interpreting Alzheimer’s biomarkers and kidney function.
DEMENTIA & HOLIDAY PLANS: Relatives with dementia may be frail or have special emotional, mental and physical health needs. Check out these ways to help them enjoy the holiday season.
Three major GLP-1 trials came out in late 2025. One weight-loss drug slowed early Alzheimer’s decline, while two others failed. Surprisingly, this mixed pattern may point the way toward a promising new treatment direction.
Most of the time, it takes a combination of genetics, bad environment and unhealthy lifestyle to trigger Alzheimer’s. However, one gene called apolipoprotein E (APOE) can make a big difference.
In a study on health & cynicism, people were asked how much they agree with statements such as, “I think most people would lie to get ahead,” and “It is safer to trust nobody”. The clear connection between their answers and their risk of dementia may startle you.
Lewis Hornby had a problem: his grandmother with dementia wasn’t drinking enough, causing her to get severely dehydrated.
Dr. Richard Taylor has Alzheimer’s and the right attitude!
No spam, only news and updates.
